|
|
||||||||
AJP - Lung Cellular and Molecular Physiology, Vol 272, Issue 5 916-L924, Copyright © 1997 by American Physiological Society
ARTICLES |
S. G. Kelsen, O. O. Anakwe, M. O. Aksoy, P. J. Reddy, N. Dhanesekaran, R. Penn and J. L. Benovic
Department of Medicine, Temple University School of Medicine, Philadelphia 19140, USA.
Chronic catecholamine treatment induces beta-adrenergic receptor (beta AR) downregulation, i.e., a loss of total cell receptors. In the human respiratory tract, the mechanism(s) underlying beta AR downregulation remains poorly understood. The present study, therefore, examined the effects of 24 h of exposure to isoproterenol (Iso; 10 nM or 1 microM) on beta AR density and the rate of beta AR degradation, steady-state beta 2-adrenergic receptor (beta 2 AR) mRNA levels, and the content of Gs alpha and Gi alpha proteins in cultured human bronchial epithelial cells (i.e., the BEAS-2B cell line). beta AR density assessed by binding with [125I]iodopindolol decreased in a dose-dependent fashion with 24 h of Iso exposure. With Iso (1 microM), beta AR density decreased by approximately 82%. In contrast, forskolin (100 microM) and dibutyryl adenosine 3',5'-cyclic monophosphate (1 mM), agents that also increase adenosine 3',5'-cyclic monophosphate (cAMP) levels, had no significant effect on beta AR density. Iso exposure also elicited a concomitant decrease in Iso-stimulated cAMP but had no significant effect on the content of the G proteins G alpha i2 and Gs alpha assessed by immunoblotting and toxin-catalyzed ADP ribosylation. Of note, Iso exposure (1 microM) had no effect on steady-state levels of beta 2 AR mRNA measured both by Northern analysis and by reverse transcriptase-polymerase chain reaction. However, beta AR half-life assessed in the presence of the protein synthesis inhibitor cycloheximide was reduced by approximately 60% in Iso-treated cells (i.e., from 37 h in control to 16 h in 1 microM Iso). These results suggest that, in human airway epithelial cells, beta 2 AR downregulation 1) is not primarily driven by intracellular cAMP levels, 2) is not associated with significant decreases in steady-state levels of beta 2 AR mRNA, and 3) is largely posttranslationally regulated by increases in the rate of receptor protein degradation.
This article has been cited by other articles:
![]() |
S. G. Kelsen, M. O. Aksoy, Y. Yang, S. Shahabuddin, J. Litvin, F. Safadi, and T. J. Rogers The chemokine receptor CXCR3 and its splice variant are expressed in human airway epithelial cells Am J Physiol Lung Cell Mol Physiol, September 1, 2004; 287(3): L584 - L591. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O. Aksoy, W. Bin, Y. Yang, D. Yun-You, and S. G. Kelsen Nuclear factor-kappa B augments beta 2-adrenergic receptor expression in human airway epithelial cells Am J Physiol Lung Cell Mol Physiol, November 1, 2001; 281(5): L1271 - L1278. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Williams, R. Barber, and R. B. Clark Kinetic Analysis of Agonist-Induced Down-Regulation of the beta 2-Adrenergic Receptor in BEAS-2B Cells Reveals High- and Low-Affinity Components Mol. Pharmacol., August 1, 2000; 58(2): 421 - 430. [Abstract] [Full Text] |
||||
![]() |
D. J. Romberger, P. Heires, S. I. Rennard, and T. A. Wyatt beta -Adrenergic agonist modulation of monocyte adhesion to airway epithelial cells in vitro Am J Physiol Lung Cell Mol Physiol, January 1, 2000; 278(1): L139 - L147. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Modelska, M. A. Matthay, L. A. S. Brown, E. Deutch, L. N. Lu, and J. F. Pittet Inhibition of beta -adrenergic-dependent alveolar epithelial clearance by oxidant mechanisms after hemorrhagic shock Am J Physiol Lung Cell Mol Physiol, May 1, 1999; 276(5): L844 - L857. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E. Morgan, C. M. Hodnichak, S. M. Stader, K. C. Maender, J. W. Boja, H. G. Folkesson, and M. B. Maron Alveolar Epithelial Ion and Fluid Transport: Prolonged isoproterenol infusion impairs the ability of beta 2-agonists to increase alveolar liquid clearance Am J Physiol Lung Cell Mol Physiol, April 1, 2002; 282(4): L666 - L674. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |